“…Brain irradiation (BI) is an essential treatment modality in a variety of oncological disorders and includes whole brain radiotherapy (WBRT) or stereotactic radiotherapy (SRT) for brain metastases (BM), prophylactic cranial irradiation (PCI) for small cell lung cancer patients, cranial irradiation or SRT in primary brain tumors (PBT) and other cerebral pathologies [1][2][3]. Despite many benefits of cranial irradiation, e.g., improved local control (LC) and overall survival (OS) [4,5], focus has recently shifted to the adverse events associated with the treatment, particularly neurocognitive decline and a decreased quality of life (QoL) in irradiated patients [6,7]. Clinical evidence indicates that three months after BI, patients suffer from impairment in memory function, in particular immediate and delayed recall [8], which is the result of radiation-induced injury to the brain neurogenic zones including the hippocampus [4].…”